SI2195312T1 - Derivati piridina, uporabni kot aktivatorji glukokinaze - Google Patents
Derivati piridina, uporabni kot aktivatorji glukokinazeInfo
- Publication number
- SI2195312T1 SI2195312T1 SI200830846T SI200830846T SI2195312T1 SI 2195312 T1 SI2195312 T1 SI 2195312T1 SI 200830846 T SI200830846 T SI 200830846T SI 200830846 T SI200830846 T SI 200830846T SI 2195312 T1 SI2195312 T1 SI 2195312T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyridine derivatives
- derivatives useful
- glucokinase activators
- glucokinase
- activators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07019691 | 2007-10-09 | ||
EP08001168 | 2008-01-23 | ||
PCT/EP2008/006649 WO2009046784A1 (en) | 2007-10-09 | 2008-08-13 | Pyridine derivatives useful as glucokinase activators |
EP08785525A EP2195312B1 (en) | 2007-10-09 | 2008-08-13 | Pyridine derivatives useful as glucokinase activators |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2195312T1 true SI2195312T1 (sl) | 2013-01-31 |
Family
ID=39870670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200830846T SI2195312T1 (sl) | 2007-10-09 | 2008-08-13 | Derivati piridina, uporabni kot aktivatorji glukokinaze |
Country Status (22)
Country | Link |
---|---|
US (1) | US8420642B2 (sl) |
EP (1) | EP2195312B1 (sl) |
JP (1) | JP5567481B2 (sl) |
KR (1) | KR20100090250A (sl) |
CN (1) | CN101821264A (sl) |
AR (1) | AR068748A1 (sl) |
AU (1) | AU2008310097B2 (sl) |
BR (1) | BRPI0818658A2 (sl) |
CA (1) | CA2701806A1 (sl) |
CY (1) | CY1113767T1 (sl) |
DK (1) | DK2195312T3 (sl) |
EA (1) | EA201000561A1 (sl) |
EC (1) | ECSP10010158A (sl) |
ES (1) | ES2399469T3 (sl) |
HR (1) | HRP20120948T1 (sl) |
IL (1) | IL204746A0 (sl) |
MX (1) | MX2010003759A (sl) |
NZ (1) | NZ585236A (sl) |
PL (1) | PL2195312T3 (sl) |
PT (1) | PT2195312E (sl) |
SI (1) | SI2195312T1 (sl) |
WO (1) | WO2009046784A1 (sl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3078662A1 (en) | 2007-09-21 | 2016-10-12 | Array Biopharma, Inc. | Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP3936608A1 (en) | 2010-03-31 | 2022-01-12 | The Scripps Research Institute | Reprogramming cells |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
JPWO2012121314A1 (ja) | 2011-03-09 | 2014-07-17 | 第一三共株式会社 | ジピリジルアミン誘導体 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN104230892B (zh) * | 2011-11-09 | 2016-12-07 | 福建海西新药创制有限公司 | 一组提高激酶活性的化合物及其应用 |
CN104144915B (zh) | 2012-02-28 | 2016-08-24 | 安斯泰来制药有限公司 | 含氮芳香族杂环化合物 |
US9365556B2 (en) | 2012-03-16 | 2016-06-14 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
CN103664759A (zh) * | 2013-12-06 | 2014-03-26 | 常熟市联创化学有限公司 | 一种3-羟基-2-硝基吡啶的制备方法 |
US9546163B2 (en) | 2014-12-23 | 2017-01-17 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
JP6483272B2 (ja) * | 2015-02-17 | 2019-03-13 | グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス,チャイニーズ アカデミー オブ サイエンスィズ | 白色脂肪組織の褐色化を誘導するための化合物および方法 |
WO2016164703A1 (en) * | 2015-04-09 | 2016-10-13 | Eisai R & D Management Co., Ltd. | Fgfr4 inhibitors |
CN110568100B (zh) * | 2019-09-12 | 2022-05-31 | 江西金水宝制药有限公司 | 一种米格列奈钙r-异构体的检测方法 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3575130D1 (de) * | 1984-05-12 | 1990-02-08 | Fisons Plc | Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung. |
CA1305478C (en) * | 1986-11-06 | 1992-07-21 | Margaret H. Sherlock | Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof |
JPH07285962A (ja) | 1994-04-20 | 1995-10-31 | Nissan Chem Ind Ltd | ピリジンカルボン酸アミド誘導体 |
EP0790057B1 (en) | 1994-11-29 | 2002-06-05 | Hisamitsu Pharmaceutical Co., Inc. | Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
WO1996018616A1 (en) | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
WO1996018617A1 (en) | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
ATE309241T1 (de) | 1999-09-10 | 2005-11-15 | Merck & Co Inc | Tyrosin kinase inhibitoren |
PE20020665A1 (es) | 2000-06-15 | 2002-08-14 | Pharmacia Corp | ACIDO CICLOALQUIL FENIL ALCANOICO COMO ANTAGONISTA DE INTEGRINAS OVß3 |
ATE287888T1 (de) * | 2000-07-04 | 2005-02-15 | Neurosearch As | Aryl- und heteroaryldiazabicycloalkane, deren zubereitung und verwendung |
EP1578341A2 (en) | 2000-10-11 | 2005-09-28 | Tularik Inc. | Modulation of ccr4 function |
DE60117605T2 (de) | 2000-12-21 | 2006-12-07 | Bristol-Myers Squibb Co. | Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie |
AUPR688101A0 (en) | 2001-08-08 | 2001-08-30 | Luminis Pty Limited | Protein domains and their ligands |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
EP1432706A2 (en) | 2001-09-26 | 2004-06-30 | Bayer Pharmaceuticals Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
EP1336607A1 (en) | 2002-02-19 | 2003-08-20 | Novo Nordisk A/S | Amide derivatives as glucokinase activators |
BR0215212A (pt) * | 2001-12-21 | 2004-12-07 | Novo Nordisk As | Ativador de carboxamida ou sulfonamida de glicoquinase, composto, composição farmacêutica, e, uso de um composto |
US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
WO2004072068A1 (en) | 2003-02-10 | 2004-08-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
MXPA05009059A (es) * | 2003-02-26 | 2005-10-19 | Banyu Pharma Co Ltd | Derivados de heteroarilcarbamoilbenceno. |
EP1636183A1 (en) | 2003-05-16 | 2006-03-22 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
CA2537141A1 (en) * | 2003-09-02 | 2005-03-10 | Merck And Co., Inc. | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
WO2005040112A1 (en) * | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds with pgd2 antagonist activity |
CA2560286A1 (en) * | 2004-03-23 | 2005-09-29 | Banyu Pharmaceutical Co., Ltd. | Substituted quinazoline or pyridopyrimidine derivative |
CA2562242A1 (en) * | 2004-04-13 | 2005-10-27 | Icagen, Inc. | Polycylic thiazoles as potassium ion channel modulators |
US20060019967A1 (en) | 2004-07-21 | 2006-01-26 | Su-Ying Wu | SARS CoV main protease inhibitors |
EA201890903A9 (ru) | 2004-09-02 | 2021-11-10 | Дженентек, Инк. | Соединения пиридиловых ингибиторов передачи сигналов белком hedgehog, способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе |
US7645778B2 (en) | 2005-01-19 | 2010-01-12 | Bristol-Myers Squibb Company | Heteroaryl compounds as P2Y1 receptor inhibitors |
AU2006227833A1 (en) | 2005-03-18 | 2006-09-28 | The Regents Of The University Of California | Compounds having activity in correcting mutant-CFTR processing and uses thereof |
AU2006241825A1 (en) * | 2005-04-28 | 2006-11-09 | Mitsubishi Tanabe Pharma Corporation | Cyanopyridine derivative and use thereof as medicine |
UA92746C2 (en) * | 2005-05-09 | 2010-12-10 | Акилайон Фармасьютикалз, Инк. | Thiazole compounds and methods of use |
NZ575514A (en) * | 2005-07-09 | 2009-11-27 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
EP1906955A2 (en) | 2005-07-21 | 2008-04-09 | Betagenon AB | Use of thiazole derivatives and analogues in the treatment of cancer |
KR20080031997A (ko) | 2005-08-02 | 2008-04-11 | 아이알엠 엘엘씨 | 단백질 키나제 억제제로서의 5-치환 티아졸-2-일 아미노화합물 및 조성물 |
WO2007023382A2 (en) | 2005-08-25 | 2007-03-01 | Pfizer Inc. | Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
JP5137207B2 (ja) | 2005-11-01 | 2013-02-06 | アレイ バイオファーマ、インコーポレイテッド | グルコキナーゼ活性化因子 |
EP1948645A1 (en) * | 2005-11-03 | 2008-07-30 | Prosidion Limited | Tricyclo substituted amides |
ES2378704T3 (es) * | 2006-01-27 | 2012-04-17 | Array Biopharma, Inc. | Activadores de la glucocinasa |
RS53981B1 (en) * | 2006-03-24 | 2015-10-30 | Array Biopharma Inc. | 2-AMINOPYRIDINE ANALYSIS AS GLUCOCINASE ACTIVATORS |
US8431713B2 (en) * | 2007-01-24 | 2013-04-30 | Array Biopharma, Inc. | 2-aminopyridine derivatives as glucokinase activators |
JP2010520887A (ja) * | 2007-03-09 | 2010-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | 蛋白キナーゼの阻害剤として有用なアミノピリジン |
CN101679405A (zh) * | 2007-03-23 | 2010-03-24 | 阵列生物制药公司 | 作为葡萄糖激酶活性剂的2-氨基吡啶类似物 |
UA99459C2 (en) * | 2007-05-04 | 2012-08-27 | Астразенека Аб | 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
-
2008
- 2008-08-13 AU AU2008310097A patent/AU2008310097B2/en not_active Ceased
- 2008-08-13 EA EA201000561A patent/EA201000561A1/ru unknown
- 2008-08-13 PL PL08785525T patent/PL2195312T3/pl unknown
- 2008-08-13 BR BRPI0818658 patent/BRPI0818658A2/pt not_active IP Right Cessation
- 2008-08-13 KR KR1020107010217A patent/KR20100090250A/ko not_active Application Discontinuation
- 2008-08-13 SI SI200830846T patent/SI2195312T1/sl unknown
- 2008-08-13 US US12/682,055 patent/US8420642B2/en active Active
- 2008-08-13 WO PCT/EP2008/006649 patent/WO2009046784A1/en active Application Filing
- 2008-08-13 MX MX2010003759A patent/MX2010003759A/es active IP Right Grant
- 2008-08-13 JP JP2010528282A patent/JP5567481B2/ja active Active
- 2008-08-13 DK DK08785525.0T patent/DK2195312T3/da active
- 2008-08-13 CN CN200880111050A patent/CN101821264A/zh active Pending
- 2008-08-13 ES ES08785525T patent/ES2399469T3/es active Active
- 2008-08-13 PT PT87855250T patent/PT2195312E/pt unknown
- 2008-08-13 CA CA2701806A patent/CA2701806A1/en not_active Abandoned
- 2008-08-13 NZ NZ585236A patent/NZ585236A/en not_active IP Right Cessation
- 2008-08-13 EP EP08785525A patent/EP2195312B1/en active Active
- 2008-10-08 AR ARP080104388A patent/AR068748A1/es unknown
-
2010
- 2010-03-25 IL IL204746A patent/IL204746A0/en unknown
- 2010-05-05 EC EC2010010158A patent/ECSP10010158A/es unknown
-
2012
- 2012-11-21 HR HRP20120948AT patent/HRP20120948T1/hr unknown
-
2013
- 2013-01-24 CY CY20131100069T patent/CY1113767T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008310097B2 (en) | 2013-05-16 |
ES2399469T3 (es) | 2013-04-01 |
KR20100090250A (ko) | 2010-08-13 |
AR068748A1 (es) | 2009-12-02 |
DK2195312T3 (da) | 2013-01-02 |
EA201000561A1 (ru) | 2010-10-29 |
CA2701806A1 (en) | 2009-04-16 |
IL204746A0 (en) | 2010-11-30 |
US8420642B2 (en) | 2013-04-16 |
JP5567481B2 (ja) | 2014-08-06 |
PT2195312E (pt) | 2013-02-20 |
MX2010003759A (es) | 2010-04-21 |
ECSP10010158A (es) | 2010-06-29 |
AU2008310097A1 (en) | 2009-04-16 |
EP2195312A1 (en) | 2010-06-16 |
WO2009046784A1 (en) | 2009-04-16 |
CN101821264A (zh) | 2010-09-01 |
PL2195312T3 (pl) | 2013-04-30 |
JP2010540667A (ja) | 2010-12-24 |
NZ585236A (en) | 2012-03-30 |
US20100216794A1 (en) | 2010-08-26 |
EP2195312B1 (en) | 2012-11-21 |
BRPI0818658A2 (pt) | 2015-04-14 |
CY1113767T1 (el) | 2016-07-27 |
HRP20120948T1 (hr) | 2012-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL204746A0 (en) | Pyridine derivatives useful as glucokinase activators | |
ZA200809017B (en) | 2-aminopyridine analogs as glucokinase activators | |
ZA201007975B (en) | Glucokinase activators | |
IL206276A0 (en) | Pyridine derivatives | |
EP2185570A4 (en) | NOVEL GLUCCOKINASE ACTIVATORS | |
ZA201006822B (en) | Glucokinase activators | |
HK1164281A1 (en) | Benzofuranyl derivatives used as glucokinase activators | |
ZA201003875B (en) | Novel pyrimidine derivatives | |
HRP20140377T1 (en) | Pyrimidine derivatives | |
HK1155170A1 (en) | Pyridine compounds | |
ZA201006159B (en) | Pyrrolidinone glucokinase activators | |
IL196321A0 (en) | Pyrazoles as glucokinase activators | |
IL207349A0 (en) | Pyridazinone glucokinase activators | |
HK1140193A1 (en) | Glucokinase activator | |
IL205666A0 (en) | Pyridine compounds | |
ZA201007615B (en) | Aminopyridine derivatives | |
ZA201002580B (en) | Heterocyclic derivatives | |
EP2285778A4 (en) | NIKOTINAMIDDERIVATE | |
IL213210A0 (en) | Arylcyclopropylacetamide derivatives useful as glucokinase activators | |
ZA200900166B (en) | Pyrazoles as glucokinase activators | |
GB0716462D0 (en) | Pyridine derivatives | |
GB0716904D0 (en) | Pyridine derivatives |